Deep Knowledge Group: Biomarkers of Human Longevity Are Essential for Investment De-Risking and Clinical Trial Predictability, Claims New Book by Seasoned Longevity Investor and Deep Knowledge Analytics Founder
Dmitry Kaminskiy's New Book Urges Longevity Industry Players to Adopt Biomarkers of Human Longevity as the Fundamental Market-Ready Tool and Framework for Industry Stabilization, Tangible Decision
Source: finanznachrichten.de